ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in Warszawa, Mazowieckie

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Carcinoma
Small Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck
Triple Negative Breast Cancer
Colorectal Cancer

Lung Cancer trials near Warszawa, Mazowieckie, POL:

Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)

with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Docetaxel
Drug: DS-1062a

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Warsaw, Poland and 209 other locations

KRAS G12C inhibitors (sotorasib or adagrasib) in participants with KRAS G12C-positive (KRAS G12C +) advanced or metastatic non-small cell lung...

Enrolling
KRAS G12C Lung Cancer
Non-Small Cell Lung Cancer
Drug: Sotorasib
Drug: Divarasib

Phase 3

Roche
Roche

Warszawa, Poland and 61 other locations

docetaxel in patients with advanced or metastasized non-small cell lung cancer (NSCLC) and unresectable NSCLC after chemoradiothera...

Enrolling
Non-Small Cell Lung Cancer
Drug: Carboplatin
Drug: Paclitaxel

Phase 1

BioNTech
BioNTech

Warsaw, Poland and 33 other locations

The main aim of this study is to:* evaluate safety and efficacy (per Response Evaluation Criteria in Solid Tumors version 1.1 \[RECIST 1.1\]...

Active, not recruiting
Relapsed/Refractory Small Cell Lung Cancer
Drug: Tarlatamab

Phase 2

Amgen
Amgen

Otwock, Poland and 79 other locations

This is an international, randomized, open-label, Phase 3 study designed to evaluate whether the potent and selective RET inhibitor, pralsetinib, imp...

Active, not recruiting
Neoplasms by Site
Neoplasms, Nerve Tissue
Drug: Carboplatin
Drug: Nab-Paclitaxel

Phase 3

Roche
Roche

Warszawa, Poland and 89 other locations

In the SAMSON-2 study, the proposed biosimilar HD204 will be compared to its reference product EU-licensed Avastin®. The aim of the study is to demon...

Active, not recruiting
Non-small Cell Lung Cancer
Lung Cancer
Drug: Bevacizumab
Drug: Carboplatin

Phase 3

Prestige Biopharma

Warszawa, Poland and 17 other locations

the efficacy and safety of durvalumab and/or novel oncology therapies, with or without chemotherapy, for first-line Stage IV Non-Small Cell Lung...

Active, not recruiting
Metastatic Non-Small Cell Lung Cancer (NSCLC)
Drug: AZD2936
Drug: Pemetrexed

Phase 1

AstraZeneca
AstraZeneca

Warszawa, Poland and 41 other locations

overall response rate (ORR) when compared to nivolumab plus PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung...

Active, not recruiting
Metastatic Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Drug: Nab-Paclitaxel
Drug: Cisplatin

Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Warszawa, Poland and 126 other locations

A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer i...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: MEDI4736

Phase 2

AstraZeneca
AstraZeneca

Warszawa, Poland and 137 other locations

study was designed to compare the efficacy and safety of I-DXd with treatment of physician's choice in participants with relapsed small cell lung...

Enrolling
Small Cell Lung Cancer
Drug: Topotecan
Drug: Amrubicin

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Otwock, Poland and 230 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems